Pavlidis, Polychronis <br/><br/>
Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.  [electronic resource] 

 -  Inflammatory bowel diseases  Dec 2014 
 - 2239-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0000000000000206  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Chemical and Drug Induced Liver Injury--drug therapy<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hyperplasia--drug therapy<br/>Inflammatory Bowel Diseases--drug therapy<br/>Liver--drug effects<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Severity of Illness Index<br/>Thioguanine--therapeutic use<br/>Young Adult